At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
The Division of Rheumatology at is part of the multidisciplinary Schroeder Arthritis Institute at University Health Network (UHN), which is the largest arthritis program in Canada.
The mission of the Division of Rheumatology is to improve the lives of patients with autoimmune and inflammatory rheumatic diseases through research, education and clinical care. Its vision is global leadership in early diagnosis, innovative treatment and prevention of autoimmune and inflammatory rheumatic diseases.
The Division of Rheumatology has an international reputation for groundbreaking research and exceptional patient care, and it serves as a preferred teaching centre for rheumatology trainees worldwide. Breakthrough research coming out of the Division has already enabled doctors around the world to diagnose patients earlier, resulting in the prevention of irreversible damage. Early diagnoses also mean patients can receive treatments tailored to their specific needs during the first phase of their ailments, radically improving the quality of their lives.
Rheumatology is the medical specialty dealing with disorders of the joints and connective tissues, such as arthritis. With rheumatic conditions comprising over 150 diseases and syndromes – and affecting millions – these disorders give rise to huge health care expenditures and an enormous loss of work, all while diminishing the quality of life of people around the globe. Currently, more than 160,000 people in Ontario over the age of 20 suffer from some form of rheumatic disease.
Due to the increasing accuracy of prognosis, the number of patients with rheumatic diseases continues to grow around the globe. As a result, there is a demand for early intervention and specialized treatments.
The doctors in the Division of Rheumatology at University Health Network are first in their field to meet this demand. Currently, the doctors are documenting patients thoroughly in all aspects of their health, utilizing clinical features and biomarkers that are available.
By following large numbers of patients over long periods of time, patterns are being identified that further our knowledge about the disease. At this time, the doctors are working to establish a new database system to efficiently collect and store patient data. This system will allow for the systematic study of various rheumatic diseases, and is key to understanding and predicting these diseases like never before. This will ultimately lead to early intervention and specialized treatments that will improve the quality of life for the millions suffering from rheumatic diseases.
With the help of our donors we can continue to build on our world-leading research, efforts that build towards better understanding, improved treatments, and an eventual cure for rheumatic diseases. Priorities include:
For more information please contact: Anette Larsson, CFRE, Director, Campaigns, Schroeder Arthritis InstitutePhone: 416 603 5800 ext. 4059 Fax: 416 603 6224 Email: